Kailera Therapeutics Earnings
NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.61+1.61 (+16.10%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kailera Therapeutics earnings summary
In its most recent report on Aug 12, 2026 (Q2 2026), KLRA posted EPS of $-1.09.
Summary generated from market data by MetaCap's automated system. Methodology
KLRA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 12, 2026 | — | $-1.09 | — | -4.3% |
| May 26, 2026 | — | $-3,650.00 | — | -15.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.